Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

Literature DB >> 7426281

Decreased clearance of diflunisal in renal insufficiency--an alternative explanation.

E M Faed.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 1980 PMID： 7426281 PMCID： PMC1430033 DOI： 10.1111/j.1365-2125.1980.tb01744.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

8 in total

1. Persistence of antibiotics in blood of patients with acute renal failure. III. Penicillin, streptomycin, erythromycin and kanamycin.

Authors: C M KUNIN; M FINLAND
Journal: J Clin Invest Date: 1959-09 Impact factor: 14.808

2. Restrictions imposed on antibiotic therapy by renal failure.

Authors: C M KUNIN; M FINLAND
Journal: Arch Intern Med Date: 1959-12

3. Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

Authors: D J Tocco; G O Breault; A G Zacchei; S L Steelman; C V Perrier
Journal: Drug Metab Dispos Date: 1975 Nov-Dec Impact factor: 3.922

4. Measurement of clofibric acid (CPIB) metabolites in plasma of patients on clofibrate therapy.

Authors: E M Faed; E G McQueen
Journal: Clin Exp Pharmacol Physiol Date: 1979 May-Jun Impact factor: 2.557

5. Plasma half-life of clofibric acid in renal failure.

Authors: E M Faed; E G McQueen
Journal: Br J Clin Pharmacol Date: 1979-04 Impact factor: 4.335

6. Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.

Authors: G Levy
Journal: Br J Clin Pharmacol Date: 1979-12 Impact factor: 4.335

7. Oxazepam disposition in uremic patients.

Authors: I Odar-Cederlöf; J Vessman; G Alván; F Sjöqvist
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1977-01

8. Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

Authors: R Verbeeck; T B Tjandramaga; A Mullie; R Verbesselt; R Verberckmoes; P J de Schepper
Journal: Br J Clin Pharmacol Date: 1979-03 Impact factor: 4.335

8 in total

10 in total

1. Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.

Authors: R K Verbeeck; T B Tjandramaga; P J De Schepper; R Verberckmoes
Journal: Br J Clin Pharmacol Date: 1981-11 Impact factor: 4.335

2. Dosage adjustment in renal insufficiency.

Authors: G E Mawer
Journal: Br J Clin Pharmacol Date: 1982-02 Impact factor: 4.335

Review 3. Drug metabolites in renal failure: pharmacokinetic and clinical implications.

Authors: R K Verbeeck; R A Branch; G R Wilkinson
Journal: Clin Pharmacokinet Date: 1981 Sep-Oct Impact factor: 6.447

4. The influence of renal function on the enantioselective pharmacokinetics and pharmacodynamics of ketoprofen in patients with rheumatoid arthritis.

Authors: P J Hayball; R L Nation; F Bochner; L N Sansom; M J Ahern; M D Smith
Journal: Br J Clin Pharmacol Date: 1993-09 Impact factor: 4.335

5. A high-pressure liquid chromatographic methods for the assay of ketoprofen in plasma and urine, and its application to determining the urinary excretion of free and conjugated ketoprofen following oral administrations of Orudis to man.

Authors: C M Kaye; M G Sankey; J E Holt
Journal: Br J Clin Pharmacol Date: 1981-04 Impact factor: 4.335